The results of this study demonstrated that liraglutide slowed the pathological damage and improved motor deficits and mood abnormalities of mice with diabetic PD by inhibiting TNF-α-mediated necroptosis and neuroinflammation. The gene discussed is TNF; the disease is diabetes mellitus.